Grifols Deutschland GmbH

Track this competitor Create a free account to be notified when it wins a contract.

Contracts won: 2
Amount won alone: €216,001 excl. VAT
Period: 3 September 2026 – 29 September 2026

Its main clients

AOK Baden-Württemberg · 1 contract
AOK Sachsen - Anhalt · 1 contract

Where and what

Supplies · 2

Its contracts coming to an end

So many opportunities to take over these contracts when they are re-tendered.

Planned end	Contract	Current holder	Amount
31 August 2028 re-tender around March 2028	Arzneimittelrabattvertrag nach § 130a Abs. 8 SGB V i.V.m. § 130c Abs. 1 SGB V zu dem Arzneimittel Fanhdi (B02BD06) zur Behandlung der Hämophilie AOK Sachsen - Anhalt	Grifols Deutschland GmbH 1 bid received	€1
31 August 2028 re-tender around March 2028	Arzneimittelrabattvereinbarung nach § 130a Abs. 8 SGB V zu dem Wirkstoff Blutgerinnungsfaktor VIII (human) (Fanhdi®) AOK Baden-Württemberg framework agreement	Grifols Deutschland GmbH 1 bid received	€216,000

Contracts won

Date	Contract	Buyer	Amount
29/09/2026	Arzneimittelrabattvereinbarung nach § 130a Abs. 8 SGB V zu dem Wirkstoff Blutgerinnungsfaktor VIII (human) (Fanhdi®)	AOK Baden-Württemberg	€216,000
03/09/2026	Arzneimittelrabattvertrag nach § 130a Abs. 8 SGB V i.V.m. § 130c Abs. 1 SGB V zu dem Arzneimittel Fanhdi (B02BD06) zur Behandlung der Hämophilie	AOK Sachsen - Anhalt	€1

Source: contract award notices published on TED (Publications Office of the European Union), above the EU thresholds. Contracts published only in Belgium are not included yet.